HEADER TRANSFERASE 21-SEP-12 4BBE TITLE AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: PROTEIN TYROSINE KINASE DOMAIN, RESIDUES 839-1132; COMPND 5 SYNONYM: JANUS KINASE 2, JAK-2; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE, INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR J.LI REVDAT 3 01-MAY-24 4BBE 1 REMARK REVDAT 2 19-DEC-12 4BBE 1 JRNL REVDAT 1 21-NOV-12 4BBE 0 JRNL AUTH T.FORSYTH,P.C.KEARNEY,B.G.KIM,H.W.B.JOHNSON,N.AAY,A.ARCALAS, JRNL AUTH 2 D.S.BROWN,V.CHAN,J.CHEN,H.DU,S.EPSHTEYN,A.A.GALAN,T.P.HUYNH, JRNL AUTH 3 M.A.IBRAHIM,B.KANE,E.KOLTUN,G.MANN,L.E.MEYR,M.S.LEE, JRNL AUTH 4 G.L.LEWIS,R.T.NOGUCHI,M.PACK,B.H.RIDGWAY,X.SHI,C.S.TAKEUCHI, JRNL AUTH 5 P.ZU,J.W.LEAHY,J.M.NUSS,R.AOYAMA,S.ENGST,S.B.GENDREAU, JRNL AUTH 6 R.KASSEES,J.LI,S.-H.LIN,J.-F.MARTINI,T.STOUT,P.TONG, JRNL AUTH 7 J.WOOLFREY,W.ZHANG,P.YU JRNL TITL SAR AND IN VIVO EVALUATION OF 4-ARYL-2-AMINOALKYLPYRIMIDINES JRNL TITL 2 AS POTENT AND SELECTIVE JANUS KINASE 2 (JAK2) INHIBITORS JRNL REF BIOORG.MED.CHEM.LETT. V. 22 7653 2012 JRNL REFN ISSN 0960-894X JRNL PMID 23127890 JRNL DOI 10.1016/J.BMCL.2012.10.007 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.5 REMARK 3 NUMBER OF REFLECTIONS : 59243 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.344 REMARK 3 R VALUE (WORKING SET) : 0.344 REMARK 3 FREE R VALUE : 0.359 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5357 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 6352 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 78.90 REMARK 3 BIN R VALUE (WORKING SET) : 0.4350 REMARK 3 BIN FREE R VALUE SET COUNT : 344 REMARK 3 BIN FREE R VALUE : 0.4340 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9516 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 116 REMARK 3 SOLVENT ATOMS : 85 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.266 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.218 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.194 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.563 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.874 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.861 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 9860 ; 0.006 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 13276 ; 0.878 ; 1.979 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1148 ; 4.081 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 500 ;34.178 ;23.920 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1832 ;13.363 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 76 ;10.772 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1376 ; 0.059 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7516 ; 0.001 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 4419 ; 0.144 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 6693 ; 0.293 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 264 ; 0.088 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 182 ; 0.166 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 14 ; 0.098 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 6032 ; 0.102 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 9292 ; 0.184 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 4488 ; 0.082 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3984 ; 0.134 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4BBE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-SEP-12. REMARK 100 THE DEPOSITION ID IS D_1290054159. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JAN-06 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.973538 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59243 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 80.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 3.030 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.70000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: IN-HOUSE STRUCTURE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 837 REMARK 465 SER A 838 REMARK 465 ARG A 839 REMARK 465 ASP A 840 REMARK 465 ASN A 1129 REMARK 465 MET A 1130 REMARK 465 ALA A 1131 REMARK 465 GLY A 1132 REMARK 465 GLU A 1133 REMARK 465 PHE A 1134 REMARK 465 GLY B 837 REMARK 465 SER B 838 REMARK 465 ARG B 839 REMARK 465 ASP B 840 REMARK 465 ASN B 1129 REMARK 465 MET B 1130 REMARK 465 ALA B 1131 REMARK 465 GLY B 1132 REMARK 465 GLU B 1133 REMARK 465 PHE B 1134 REMARK 465 GLY C 837 REMARK 465 SER C 838 REMARK 465 ARG C 839 REMARK 465 ASP C 840 REMARK 465 ASN C 1129 REMARK 465 MET C 1130 REMARK 465 ALA C 1131 REMARK 465 GLY C 1132 REMARK 465 GLU C 1133 REMARK 465 PHE C 1134 REMARK 465 GLY D 837 REMARK 465 SER D 838 REMARK 465 ARG D 839 REMARK 465 ASP D 840 REMARK 465 ASN D 1129 REMARK 465 MET D 1130 REMARK 465 ALA D 1131 REMARK 465 GLY D 1132 REMARK 465 GLU D 1133 REMARK 465 PHE D 1134 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 872 CB CG CD OE1 NE2 REMARK 470 GLN B 872 CB CG CD OE1 NE2 REMARK 470 GLN C 872 CB CG CD OE1 NE2 REMARK 470 GLN D 872 CB CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 848 -153.11 -94.35 REMARK 500 LEU A 849 82.60 56.68 REMARK 500 LEU A 852 -55.24 -123.02 REMARK 500 ASP A 873 -92.99 49.91 REMARK 500 ASN A 874 -23.90 -148.43 REMARK 500 THR A 888 -155.17 -125.99 REMARK 500 HIS A 944 44.68 -151.71 REMARK 500 LYS A 945 -94.48 162.04 REMARK 500 ASP A 949 -163.24 -111.53 REMARK 500 ARG A 975 -4.46 65.81 REMARK 500 ASN A 976 48.21 -143.38 REMARK 500 ASP A 994 81.25 51.58 REMARK 500 PRO A1013 -95.32 -24.06 REMARK 500 PRO A1017 80.65 -67.90 REMARK 500 GLN A1072 -41.14 58.58 REMARK 500 TRP A1106 53.44 -90.04 REMARK 500 HIS B 848 -155.91 -93.52 REMARK 500 LEU B 849 81.89 62.82 REMARK 500 LEU B 855 -63.54 -92.14 REMARK 500 ASN B 874 -38.70 67.03 REMARK 500 ARG B 975 -0.20 65.48 REMARK 500 ASN B 976 53.54 -147.34 REMARK 500 ASP B 994 85.32 54.58 REMARK 500 PRO B1013 -104.91 -14.22 REMARK 500 PRO B1017 76.77 -69.38 REMARK 500 GLN B1072 -40.26 58.25 REMARK 500 ASN B1084 43.50 -107.53 REMARK 500 THR C 842 -73.83 20.03 REMARK 500 ASP C 873 -91.32 44.84 REMARK 500 ASN C 874 -27.37 -154.81 REMARK 500 ARG C 971 79.49 56.69 REMARK 500 TYR C 972 77.22 85.47 REMARK 500 ARG C 975 -1.03 66.51 REMARK 500 ASN C 976 52.55 -147.59 REMARK 500 ASP C 994 82.16 51.59 REMARK 500 PRO C1013 -109.09 -15.06 REMARK 500 PRO C1017 81.68 -67.78 REMARK 500 GLN C1072 -51.63 62.70 REMARK 500 HIS D 848 -126.26 -96.57 REMARK 500 GLN D 872 42.75 112.96 REMARK 500 ASP D 873 -112.68 -134.48 REMARK 500 ASN D 874 -16.12 -141.82 REMARK 500 THR D 888 -143.08 -123.88 REMARK 500 ASP D 949 -106.51 -92.09 REMARK 500 ARG D 975 -4.30 65.09 REMARK 500 ASN D 976 49.84 -141.76 REMARK 500 ASP D 994 81.86 52.52 REMARK 500 PRO D1013 -74.57 -26.43 REMARK 500 PRO D1017 81.17 -68.04 REMARK 500 GLN D1072 -39.27 61.66 REMARK 500 REMARK 500 THIS ENTRY HAS 51 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3O4 A 2229 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3O4 B 2229 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3O4 C 2229 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3O4 D 2229 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2B7A RELATED DB: PDB REMARK 900 THE STRUCTURAL BASIS OF JANUS KINASE 2 INHIBITION BY APOTENT AND REMARK 900 SPECIFIC PAN-JANUS KINASE INHIBITOR REMARK 900 RELATED ID: 2W1I RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2XA4 RELATED DB: PDB REMARK 900 INHIBITORS OF JAK2 KINASE DOMAIN REMARK 900 RELATED ID: 4AQC RELATED DB: PDB REMARK 900 TRIAZOLOPYRIDINE-BASED INHIBITOR OF JANUS KINASE 2 REMARK 900 RELATED ID: 4BBF RELATED DB: PDB REMARK 900 AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2 DBREF 4BBE A 839 1132 UNP O60674 JAK2_HUMAN 839 1132 DBREF 4BBE B 839 1132 UNP O60674 JAK2_HUMAN 839 1132 DBREF 4BBE C 839 1132 UNP O60674 JAK2_HUMAN 839 1132 DBREF 4BBE D 839 1132 UNP O60674 JAK2_HUMAN 839 1132 SEQADV 4BBE GLY A 837 UNP O60674 EXPRESSION TAG SEQADV 4BBE SER A 838 UNP O60674 EXPRESSION TAG SEQADV 4BBE ASN A 976 UNP O60674 ASP 976 ENGINEERED MUTATION SEQADV 4BBE GLU A 1133 UNP O60674 EXPRESSION TAG SEQADV 4BBE PHE A 1134 UNP O60674 EXPRESSION TAG SEQADV 4BBE GLY B 837 UNP O60674 EXPRESSION TAG SEQADV 4BBE SER B 838 UNP O60674 EXPRESSION TAG SEQADV 4BBE ASN B 976 UNP O60674 ASP 976 ENGINEERED MUTATION SEQADV 4BBE GLU B 1133 UNP O60674 EXPRESSION TAG SEQADV 4BBE PHE B 1134 UNP O60674 EXPRESSION TAG SEQADV 4BBE GLY C 837 UNP O60674 EXPRESSION TAG SEQADV 4BBE SER C 838 UNP O60674 EXPRESSION TAG SEQADV 4BBE ASN C 976 UNP O60674 ASP 976 ENGINEERED MUTATION SEQADV 4BBE GLU C 1133 UNP O60674 EXPRESSION TAG SEQADV 4BBE PHE C 1134 UNP O60674 EXPRESSION TAG SEQADV 4BBE GLY D 837 UNP O60674 EXPRESSION TAG SEQADV 4BBE SER D 838 UNP O60674 EXPRESSION TAG SEQADV 4BBE ASN D 976 UNP O60674 ASP 976 ENGINEERED MUTATION SEQADV 4BBE GLU D 1133 UNP O60674 EXPRESSION TAG SEQADV 4BBE PHE D 1134 UNP O60674 EXPRESSION TAG SEQRES 1 A 298 GLY SER ARG ASP PRO THR GLN PHE GLU GLU ARG HIS LEU SEQRES 2 A 298 LYS PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE GLY SER SEQRES 3 A 298 VAL GLU MET CYS ARG TYR ASP PRO LEU GLN ASP ASN THR SEQRES 4 A 298 GLY GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SER THR SEQRES 5 A 298 GLU GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE GLU ILE SEQRES 6 A 298 LEU LYS SER LEU GLN HIS ASP ASN ILE VAL LYS TYR LYS SEQRES 7 A 298 GLY VAL CYS TYR SER ALA GLY ARG ARG ASN LEU LYS LEU SEQRES 8 A 298 ILE MET GLU TYR LEU PRO TYR GLY SER LEU ARG ASP TYR SEQRES 9 A 298 LEU GLN LYS HIS LYS GLU ARG ILE ASP HIS ILE LYS LEU SEQRES 10 A 298 LEU GLN TYR THR SER GLN ILE CYS LYS GLY MET GLU TYR SEQRES 11 A 298 LEU GLY THR LYS ARG TYR ILE HIS ARG ASN LEU ALA THR SEQRES 12 A 298 ARG ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL LYS ILE SEQRES 13 A 298 GLY ASP PHE GLY LEU THR LYS VAL LEU PRO GLN ASP LYS SEQRES 14 A 298 GLU TYR TYR LYS VAL LYS GLU PRO GLY GLU SER PRO ILE SEQRES 15 A 298 PHE TRP TYR ALA PRO GLU SER LEU THR GLU SER LYS PHE SEQRES 16 A 298 SER VAL ALA SER ASP VAL TRP SER PHE GLY VAL VAL LEU SEQRES 17 A 298 TYR GLU LEU PHE THR TYR ILE GLU LYS SER LYS SER PRO SEQRES 18 A 298 PRO ALA GLU PHE MET ARG MET ILE GLY ASN ASP LYS GLN SEQRES 19 A 298 GLY GLN MET ILE VAL PHE HIS LEU ILE GLU LEU LEU LYS SEQRES 20 A 298 ASN ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS PRO ASP SEQRES 21 A 298 GLU ILE TYR MET ILE MET THR GLU CYS TRP ASN ASN ASN SEQRES 22 A 298 VAL ASN GLN ARG PRO SER PHE ARG ASP LEU ALA LEU ARG SEQRES 23 A 298 VAL ASP GLN ILE ARG ASP ASN MET ALA GLY GLU PHE SEQRES 1 B 298 GLY SER ARG ASP PRO THR GLN PHE GLU GLU ARG HIS LEU SEQRES 2 B 298 LYS PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE GLY SER SEQRES 3 B 298 VAL GLU MET CYS ARG TYR ASP PRO LEU GLN ASP ASN THR SEQRES 4 B 298 GLY GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SER THR SEQRES 5 B 298 GLU GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE GLU ILE SEQRES 6 B 298 LEU LYS SER LEU GLN HIS ASP ASN ILE VAL LYS TYR LYS SEQRES 7 B 298 GLY VAL CYS TYR SER ALA GLY ARG ARG ASN LEU LYS LEU SEQRES 8 B 298 ILE MET GLU TYR LEU PRO TYR GLY SER LEU ARG ASP TYR SEQRES 9 B 298 LEU GLN LYS HIS LYS GLU ARG ILE ASP HIS ILE LYS LEU SEQRES 10 B 298 LEU GLN TYR THR SER GLN ILE CYS LYS GLY MET GLU TYR SEQRES 11 B 298 LEU GLY THR LYS ARG TYR ILE HIS ARG ASN LEU ALA THR SEQRES 12 B 298 ARG ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL LYS ILE SEQRES 13 B 298 GLY ASP PHE GLY LEU THR LYS VAL LEU PRO GLN ASP LYS SEQRES 14 B 298 GLU TYR TYR LYS VAL LYS GLU PRO GLY GLU SER PRO ILE SEQRES 15 B 298 PHE TRP TYR ALA PRO GLU SER LEU THR GLU SER LYS PHE SEQRES 16 B 298 SER VAL ALA SER ASP VAL TRP SER PHE GLY VAL VAL LEU SEQRES 17 B 298 TYR GLU LEU PHE THR TYR ILE GLU LYS SER LYS SER PRO SEQRES 18 B 298 PRO ALA GLU PHE MET ARG MET ILE GLY ASN ASP LYS GLN SEQRES 19 B 298 GLY GLN MET ILE VAL PHE HIS LEU ILE GLU LEU LEU LYS SEQRES 20 B 298 ASN ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS PRO ASP SEQRES 21 B 298 GLU ILE TYR MET ILE MET THR GLU CYS TRP ASN ASN ASN SEQRES 22 B 298 VAL ASN GLN ARG PRO SER PHE ARG ASP LEU ALA LEU ARG SEQRES 23 B 298 VAL ASP GLN ILE ARG ASP ASN MET ALA GLY GLU PHE SEQRES 1 C 298 GLY SER ARG ASP PRO THR GLN PHE GLU GLU ARG HIS LEU SEQRES 2 C 298 LYS PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE GLY SER SEQRES 3 C 298 VAL GLU MET CYS ARG TYR ASP PRO LEU GLN ASP ASN THR SEQRES 4 C 298 GLY GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SER THR SEQRES 5 C 298 GLU GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE GLU ILE SEQRES 6 C 298 LEU LYS SER LEU GLN HIS ASP ASN ILE VAL LYS TYR LYS SEQRES 7 C 298 GLY VAL CYS TYR SER ALA GLY ARG ARG ASN LEU LYS LEU SEQRES 8 C 298 ILE MET GLU TYR LEU PRO TYR GLY SER LEU ARG ASP TYR SEQRES 9 C 298 LEU GLN LYS HIS LYS GLU ARG ILE ASP HIS ILE LYS LEU SEQRES 10 C 298 LEU GLN TYR THR SER GLN ILE CYS LYS GLY MET GLU TYR SEQRES 11 C 298 LEU GLY THR LYS ARG TYR ILE HIS ARG ASN LEU ALA THR SEQRES 12 C 298 ARG ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL LYS ILE SEQRES 13 C 298 GLY ASP PHE GLY LEU THR LYS VAL LEU PRO GLN ASP LYS SEQRES 14 C 298 GLU TYR TYR LYS VAL LYS GLU PRO GLY GLU SER PRO ILE SEQRES 15 C 298 PHE TRP TYR ALA PRO GLU SER LEU THR GLU SER LYS PHE SEQRES 16 C 298 SER VAL ALA SER ASP VAL TRP SER PHE GLY VAL VAL LEU SEQRES 17 C 298 TYR GLU LEU PHE THR TYR ILE GLU LYS SER LYS SER PRO SEQRES 18 C 298 PRO ALA GLU PHE MET ARG MET ILE GLY ASN ASP LYS GLN SEQRES 19 C 298 GLY GLN MET ILE VAL PHE HIS LEU ILE GLU LEU LEU LYS SEQRES 20 C 298 ASN ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS PRO ASP SEQRES 21 C 298 GLU ILE TYR MET ILE MET THR GLU CYS TRP ASN ASN ASN SEQRES 22 C 298 VAL ASN GLN ARG PRO SER PHE ARG ASP LEU ALA LEU ARG SEQRES 23 C 298 VAL ASP GLN ILE ARG ASP ASN MET ALA GLY GLU PHE SEQRES 1 D 298 GLY SER ARG ASP PRO THR GLN PHE GLU GLU ARG HIS LEU SEQRES 2 D 298 LYS PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE GLY SER SEQRES 3 D 298 VAL GLU MET CYS ARG TYR ASP PRO LEU GLN ASP ASN THR SEQRES 4 D 298 GLY GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SER THR SEQRES 5 D 298 GLU GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE GLU ILE SEQRES 6 D 298 LEU LYS SER LEU GLN HIS ASP ASN ILE VAL LYS TYR LYS SEQRES 7 D 298 GLY VAL CYS TYR SER ALA GLY ARG ARG ASN LEU LYS LEU SEQRES 8 D 298 ILE MET GLU TYR LEU PRO TYR GLY SER LEU ARG ASP TYR SEQRES 9 D 298 LEU GLN LYS HIS LYS GLU ARG ILE ASP HIS ILE LYS LEU SEQRES 10 D 298 LEU GLN TYR THR SER GLN ILE CYS LYS GLY MET GLU TYR SEQRES 11 D 298 LEU GLY THR LYS ARG TYR ILE HIS ARG ASN LEU ALA THR SEQRES 12 D 298 ARG ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL LYS ILE SEQRES 13 D 298 GLY ASP PHE GLY LEU THR LYS VAL LEU PRO GLN ASP LYS SEQRES 14 D 298 GLU TYR TYR LYS VAL LYS GLU PRO GLY GLU SER PRO ILE SEQRES 15 D 298 PHE TRP TYR ALA PRO GLU SER LEU THR GLU SER LYS PHE SEQRES 16 D 298 SER VAL ALA SER ASP VAL TRP SER PHE GLY VAL VAL LEU SEQRES 17 D 298 TYR GLU LEU PHE THR TYR ILE GLU LYS SER LYS SER PRO SEQRES 18 D 298 PRO ALA GLU PHE MET ARG MET ILE GLY ASN ASP LYS GLN SEQRES 19 D 298 GLY GLN MET ILE VAL PHE HIS LEU ILE GLU LEU LEU LYS SEQRES 20 D 298 ASN ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS PRO ASP SEQRES 21 D 298 GLU ILE TYR MET ILE MET THR GLU CYS TRP ASN ASN ASN SEQRES 22 D 298 VAL ASN GLN ARG PRO SER PHE ARG ASP LEU ALA LEU ARG SEQRES 23 D 298 VAL ASP GLN ILE ARG ASP ASN MET ALA GLY GLU PHE HET 3O4 A2229 29 HET 3O4 B2229 29 HET 3O4 C2229 29 HET 3O4 D2229 29 HETNAM 3O4 N-[4-[2-[(4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4- HETNAM 2 3O4 YL]PHENYL]ETHANAMIDE FORMUL 5 3O4 4(C22 H23 N5 O2) FORMUL 9 HOH *85(H2 O) HELIX 1 1 GLU A 889 LEU A 905 1 17 HELIX 2 2 SER A 936 HIS A 944 1 9 HELIX 3 3 ASP A 949 LYS A 970 1 22 HELIX 4 4 ALA A 1022 GLU A 1028 1 7 HELIX 5 5 SER A 1032 TYR A 1050 1 19 HELIX 6 6 GLU A 1052 LYS A 1055 5 4 HELIX 7 7 SER A 1056 GLY A 1066 1 11 HELIX 8 8 GLN A 1072 ASN A 1084 1 13 HELIX 9 9 PRO A 1095 TRP A 1106 1 12 HELIX 10 10 SER A 1115 ASP A 1128 1 14 HELIX 11 11 THR B 888 LEU B 905 1 18 HELIX 12 12 TYR B 918 ARG B 923 1 6 HELIX 13 13 SER B 936 HIS B 944 1 9 HELIX 14 14 LYS B 945 ILE B 948 5 4 HELIX 15 15 ASP B 949 LYS B 970 1 22 HELIX 16 16 ALA B 1022 GLU B 1028 1 7 HELIX 17 17 SER B 1032 THR B 1049 1 18 HELIX 18 18 GLU B 1052 LYS B 1055 5 4 HELIX 19 19 SER B 1056 GLY B 1066 1 11 HELIX 20 20 GLN B 1072 ASN B 1084 1 13 HELIX 21 21 PRO B 1095 TRP B 1106 1 12 HELIX 22 22 SER B 1115 ASP B 1128 1 14 HELIX 23 23 THR C 888 LEU C 905 1 18 HELIX 24 24 TYR C 918 ARG C 923 1 6 HELIX 25 25 SER C 936 HIS C 944 1 9 HELIX 26 26 LYS C 945 ILE C 948 5 4 HELIX 27 27 ASP C 949 THR C 969 1 21 HELIX 28 28 ALA C 1022 GLU C 1028 1 7 HELIX 29 29 SER C 1032 THR C 1049 1 18 HELIX 30 30 GLU C 1052 LYS C 1055 5 4 HELIX 31 31 SER C 1056 GLY C 1066 1 11 HELIX 32 32 GLN C 1072 ASN C 1084 1 13 HELIX 33 33 PRO C 1095 TRP C 1106 1 12 HELIX 34 34 SER C 1115 ASP C 1128 1 14 HELIX 35 35 GLU D 889 LEU D 905 1 17 HELIX 36 36 SER D 936 HIS D 944 1 9 HELIX 37 37 LYS D 945 ILE D 948 5 4 HELIX 38 38 HIS D 950 LYS D 970 1 21 HELIX 39 39 ALA D 1022 GLU D 1028 1 7 HELIX 40 40 SER D 1032 THR D 1049 1 18 HELIX 41 41 GLU D 1052 LYS D 1055 5 4 HELIX 42 42 SER D 1056 GLY D 1066 1 11 HELIX 43 43 GLN D 1072 ASN D 1084 1 13 HELIX 44 44 PRO D 1095 TRP D 1106 1 12 HELIX 45 45 SER D 1115 ASP D 1128 1 14 SHEET 1 AA 6 GLN A 843 PHE A 844 0 SHEET 2 AA 6 TYR A 913 SER A 919 1 O VAL A 916 N PHE A 844 SHEET 3 AA 6 ASN A 924 GLU A 930 -1 O ASN A 924 N SER A 919 SHEET 4 AA 6 GLU A 877 LEU A 884 -1 O ALA A 880 N MET A 929 SHEET 5 AA 6 GLY A 861 TYR A 868 -1 O SER A 862 N LYS A 883 SHEET 6 AA 6 LYS A 850 LYS A 857 -1 O LYS A 850 N ARG A 867 SHEET 1 AB 2 TYR A 972 ILE A 973 0 SHEET 2 AB 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 AC 2 ILE A 982 ASN A 986 0 SHEET 2 AC 2 ARG A 989 ILE A 992 -1 O ARG A 989 N ASN A 986 SHEET 1 AD 2 TYR A1008 LYS A1009 0 SHEET 2 AD 2 LYS A1030 PHE A1031 -1 O PHE A1031 N TYR A1008 SHEET 1 BA 5 LYS B 850 LYS B 857 0 SHEET 2 BA 5 GLY B 861 TYR B 868 -1 O VAL B 863 N GLY B 856 SHEET 3 BA 5 GLU B 877 LEU B 884 -1 O GLU B 877 N TYR B 868 SHEET 4 BA 5 LYS B 926 GLU B 930 -1 O LEU B 927 N LYS B 882 SHEET 5 BA 5 TYR B 913 CYS B 917 -1 N LYS B 914 O ILE B 928 SHEET 1 BB 2 TYR B 972 ILE B 973 0 SHEET 2 BB 2 LYS B 999 VAL B1000 -1 O LYS B 999 N ILE B 973 SHEET 1 BC 2 ILE B 982 ASN B 986 0 SHEET 2 BC 2 ARG B 989 ILE B 992 -1 O ARG B 989 N GLU B 985 SHEET 1 BD 2 TYR B1008 LYS B1009 0 SHEET 2 BD 2 LYS B1030 PHE B1031 -1 O PHE B1031 N TYR B1008 SHEET 1 CA 6 GLN C 843 PHE C 844 0 SHEET 2 CA 6 TYR C 913 CYS C 917 1 O VAL C 916 N PHE C 844 SHEET 3 CA 6 LYS C 926 GLU C 930 -1 O LYS C 926 N CYS C 917 SHEET 4 CA 6 GLU C 877 LEU C 884 -1 O ALA C 880 N MET C 929 SHEET 5 CA 6 GLY C 861 TYR C 868 -1 O SER C 862 N LYS C 883 SHEET 6 CA 6 LEU C 849 LYS C 857 -1 O LYS C 850 N ARG C 867 SHEET 1 CB 2 TYR C 972 ILE C 973 0 SHEET 2 CB 2 LYS C 999 VAL C1000 -1 O LYS C 999 N ILE C 973 SHEET 1 CC 2 ILE C 982 ASN C 986 0 SHEET 2 CC 2 ARG C 989 ILE C 992 -1 O ARG C 989 N ASN C 986 SHEET 1 CD 2 TYR C1008 LYS C1009 0 SHEET 2 CD 2 LYS C1030 PHE C1031 -1 O PHE C1031 N TYR C1008 SHEET 1 DA 6 GLN D 843 PHE D 844 0 SHEET 2 DA 6 TYR D 913 SER D 919 1 O VAL D 916 N PHE D 844 SHEET 3 DA 6 ASN D 924 GLU D 930 -1 O ASN D 924 N SER D 919 SHEET 4 DA 6 GLU D 877 LEU D 884 -1 O ALA D 880 N MET D 929 SHEET 5 DA 6 GLY D 861 TYR D 868 -1 O SER D 862 N LYS D 883 SHEET 6 DA 6 LYS D 850 LYS D 857 -1 O LYS D 850 N ARG D 867 SHEET 1 DB 2 TYR D 972 ILE D 973 0 SHEET 2 DB 2 LYS D 999 VAL D1000 -1 O LYS D 999 N ILE D 973 SHEET 1 DC 2 ILE D 982 ASN D 986 0 SHEET 2 DC 2 ARG D 989 ILE D 992 -1 O ARG D 989 N ASN D 986 SHEET 1 DD 2 TYR D1008 LYS D1009 0 SHEET 2 DD 2 LYS D1030 PHE D1031 -1 O PHE D1031 N TYR D1008 CISPEP 1 LEU A 871 GLN A 872 0 -0.33 CISPEP 2 HIS A 944 LYS A 945 0 -8.81 CISPEP 3 LEU B 871 GLN B 872 0 -2.06 CISPEP 4 LEU C 871 GLN C 872 0 -0.42 CISPEP 5 ARG C 971 TYR C 972 0 -12.89 SITE 1 AC1 11 LEU A 855 PHE A 860 VAL A 863 LYS A 882 SITE 2 AC1 11 GLU A 930 TYR A 931 LEU A 932 GLY A 935 SITE 3 AC1 11 LEU A 983 ASP A 994 GLN B 853 SITE 1 AC2 10 GLN A 853 LEU B 855 GLY B 856 VAL B 863 SITE 2 AC2 10 GLU B 930 TYR B 931 LEU B 932 GLY B 935 SITE 3 AC2 10 LYS B 943 LEU B 983 SITE 1 AC3 9 LEU C 855 VAL C 863 LYS C 882 MET C 929 SITE 2 AC3 9 GLU C 930 TYR C 931 LEU C 932 GLY C 935 SITE 3 AC3 9 GLN D 853 SITE 1 AC4 14 GLN C 853 LEU D 855 PHE D 860 VAL D 863 SITE 2 AC4 14 ALA D 880 LYS D 882 GLU D 930 TYR D 931 SITE 3 AC4 14 LEU D 932 GLY D 935 ASP D 939 LEU D 983 SITE 4 AC4 14 ASP D 994 HOH D2009 CRYST1 68.962 76.284 87.742 84.02 66.87 63.13 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014501 -0.007347 -0.006879 0.00000 SCALE2 0.000000 0.014696 0.001319 0.00000 SCALE3 0.000000 0.000000 0.012443 0.00000